
Sudeep Pharma IPO Allotment Status Check Online: GMP, Subscription, Price, and More
Updated: 25 Nov 2025 • 1:09 pm
Posted by:

After receiving a strong response from investors, the bidding period has finally ended for the Sudeep Pharma IPO. It has received a total of 7.80 subscriptions. The public issue subscribed 6.51 times in the individual investors category, 0.15 times in QIB, and 21.01 times in the NII category. The allotment was set to be made on 16th November 2025. Check your Sudeep Pharma IPO allotment status online.
Sudeep Pharma IPO Allotment Status
Sudeep Pharma IPO allotment status has finally been shared with the public. The company has credited the shares to the allottees’ demat accounts. MUFG Intime India Limited, registrar of this IPO, finalised the basis of allotment and is eligible to list with the T+3 rule. The public issue will be listed within 3 days of the subscription ending.
Investors can now check the Sudeep Pharma IPO allotment status on the official websites of BSE and NSE, as well as the registrar portal.
Check Allotment Status On the Registrar Portal
The individual can visit the official portal of MUFG Intime India Private Limited to learn about their allotment status. Follow the steps below to check your allotment status on the registrar portal.
Step 1: Visit the registrar’s website.
Step 2: Select Sudeep Pharma IPO from the menu.
Step 3: Select the option to check the allotment status from the application no/demat account/PAN.
Step 4: Fill in the required details to proceed further.
Step 5: Enter the captcha and click on the submit button.
The Sudeep Pharma IPO allotment status will be displayed on your screen.
Check Allotment Status On NSE
Follow the steps mentioned below to check the Sudeep Pharma IPO allotment status on the official website of NSE (National Stock Exchange).
Step 1: Visit the NSE Official Website.
Step 2: Select Issue Type as Equity to proceed.
Step 3: Scroll down through the issue names and select Sudeep Pharma IPO.
Step 4: Choose the mode from the application no or PAN.
Step 5: Submit your information.
The Sudeep Pharma IPO allotment status will be displayed on your screen.
IPO Details
| IPO Open Date | 21st November 2025 |
| Face Value | ₹1 per share |
| Price Band | ₹563 to ₹593 per share |
| Lot Size | 25 shares |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE & NSE |
| IPO Close Date | 25th November 2025 |
| Listing Date | 28th November 2025 |
Sudeep Pharma IPO Share Reservation
The Sudeep Pharma IPO is a bookbuilding IPO of ₹895.00 crores, comprising a fresh issue of 16,00,000 shares. An offer for sale of 1.35 crore shares. Sudeep Pharma Limited will be listed on the BSE and NSE. Furthermore, SEBI has specified the share reservation criteria for different investor categories.
| Investor Categories | Shares Offered | % Shares offered |
| QIB Shares Offered | 75,46,376 | 50.00% |
| Retail Shares Offered | 22,63,912 | 15.00% |
| NII (HNI) Shares Offered | 52,82,462 | 35.00% |
| Total Shares Offered | 1,50,92,750 | 100.00% |
Sudeep Pharma IPO GMP

As of 25th November 2025, the Sudeep Pharma IPO GMP stands at ₹83 per share. Thus, the estimated listing price would be ₹676. This indicates that the estimated listing gain in this IPO could be 14.00%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Sudeep Pharma IPO GMP updates.
| GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
| 25-11-2025 | ₹593.00 | ₹83.00 | ₹676.00 | 14.00% |
| 24-11-2025 | ₹593.00 | ₹90.00 | ₹683.00 | 15.18% |
| 23-11-2025 | ₹593.00 | ₹121.00 | ₹714.00 | 20.40% |
| 22-11-2025 | ₹593.00 | ₹121.00 | ₹714.00 | 20.40% |
| 21-11-2025 | ₹593.00 | ₹111.00 | ₹704.00 | 18.72% |
| 20-11-2025 | ₹593.00 | ₹122.00 | ₹715.00 | 20.57% |
| 19-11-2025 | ₹593.00 | ₹130.00 | ₹723.00 | 21.92% |
| 18-11-2025 | ₹593.00 | ₹93.00 | ₹686.00 | 15.68% |
| 17-11-2025 | ₹593.00 | ₹0.00 | ₹686.00 | 0.00% |
Sudeep Pharma IPO Timeline
| IPO Open Date | 21st November 2025 |
| IPO Close Date | 25th November 2025 |
| Allotment | 26th November 2025 |
| Refund Date | 27th November 2025 |
| IPO Listing Date | 28th November 2025 |
Note: For any query, contact MUFG Intime India Limited at ipo.helpdesk@linkintime.co.in or +91-22-4918 6270.
Recent Articles
RITES Q1 Results FY26: Q1 PAT Jumps 1.37% to ₹80.10 Crore; Revenue Surges 0.82% YoY
Godrej Agrovet Q1 Results FY26: Q1 Rises 18.77% to ₹160.52 Crore; Revenue Soars 11.21% YoY
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Libord Finance Q4 FY26 Results: Loss Rs 1.8 Cr
Gini Silk Mills Q4 FY26 Results: PAT Rs 1.2 Cr
Voltaire Leasing and Finance Q4 FY26 Results: Loss Rs 0.09 Cr
GHCL Textiles Analyst Review May 2026
M R Maniveni Foods IPO GMP Day 4 25 May 2026: GMP Rs 0, Closes Tomorrow, Chennai Pulses Processor Last Chance
Popular this week
Libord Finance Q4 FY26 Results: Loss Rs 1.8 Cr
Gini Silk Mills Q4 FY26 Results: PAT Rs 1.2 Cr
Voltaire Leasing and Finance Q4 FY26 Results: Loss Rs 0.09 Cr
GHCL Textiles Analyst Review May 2026
M R Maniveni Foods IPO GMP Day 4 25 May 2026: GMP Rs 0, Closes Tomorrow, Chennai Pulses Processor Last Chance

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas





